Switch to:
More From Other Websites
aTyr Pharma to Present at Needham and Company 16th Annual Healthcare Conference Mar 29 2017
ATYR PHARMA INC Financials Mar 22 2017
Atyr Pharma reports 4Q loss Mar 16 2017
Atyr Pharma reports 4Q loss Mar 16 2017
ATYR PHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Mar 16 2017
aTyr Pharma Announces Issuance of US Patent That Extends Patent Protection of Physiocrines Derived... Mar 15 2017
aTyr Pharma Receives EMA Orphan Drug Designation for the Treatment of Limb Girdle Muscular Dystrophy... Mar 03 2017
aTyr Pharma Rises 16% on Orphan Drug Status Mar 01 2017
aTyr Pharma to Present at Cowen and Company 37th Annual Health Care Conference Mar 01 2017
aTyr Pharma Receives U.S. FDA Orphan Drug Designation for the Treatment of Limb Girdle Muscular... Feb 28 2017
High court ruling limits international reach of patent laws Feb 22 2017
High court ruling limits international reach of patent laws Feb 22 2017
Atyr Pharma Stock Spikes 33% on FDA Updates Jan 19 2017
FDA Grants Fast Track Designation for aTyr's Resolaris™ to Treat Limb Girdle Muscular Dystrophy 2B... Jan 18 2017
ATYR PHARMA INC Files SEC form 8-K, Regulation FD Disclosure Jan 09 2017
Roberts recuses from patent case after discovering conflict Jan 04 2017
Roberts recuses from patent case after discovering conflict Jan 04 2017
Atyr Pharma Inc (LIFE) CEO and Director John Mendlein Bought $151,800 of Shares Dec 21 2016
Does aTyr Pharma Inc (LIFE) Stack Up Against Its Peers? Dec 16 2016
aTyr Pharma Drops on Clinical Update Dec 13 2016


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK